Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry-Reference-Cited by-同舟云学术

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry

Published:2017-07-14 Issue:1 Volume:18 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Kreuter Michael,Swigris Jeff,Pittrow David,Geier Silke,Klotsche Jens,Prasse Antje,Wirtz Hubert,Koschel Dirk,Andreas Stefan,Claussen Martin,Grohé Christian,Wilkens Henrike,Hagmeyer Lars,Skowasch Dirk,Meyer Joachim F,Kirschner Joachim,Gläser Sven,Herth Felix J. F.,Welte Tobias,Neurohr Claus,Schwaiblmair Martin,Held Matthias,Bahmer Thomas,Frankenberger Marion,Behr Jürgen

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s12931-017-0621-y.pdf

Reference40 articles.

1. Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohe C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Glaser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhaufl M, Hoffken G, Held M, Koch A, Bahmer T, Pittrow D. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J. 2015;46(1):186–96.

2. Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schunemann HJ. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3–19.

3. Kreuter M, Ehlers-Tenenbaum S, Palmowski K, Bruhwyler J, Oltmanns U, Muley T, Heussel CP, Warth A, Kolb M, Herth FJ. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One. 2016;11(3):e0151425.

4. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007;176(3):277–84.

5. Rochwerg B, Neupane B, Zhang Y, Garcia CC, Raghu G, Richeldi L, Brozek J, Beyene J, Schunemann H. Treatment of idiopathic pulmonary fibrosis: a network meta-analysis. BMC Med. 2016;14:18.

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiopathic Pulmonary Fibrosis: Review of Current Knowledge;Physiological Research;2024-08-31

2. Clinical and economic burden of acute exacerbations of idiopathic pulmonary fibrosis: a prospective observational study in Spain (OASIS study);BMC Pulmonary Medicine;2024-07-31

3. A Randomized Controlled Trial of the Safety and Efficacy of Systemic Enzyme Supplementation on Symptoms and Quality of Life in Patients with Idiopathic Pulmonary Fibrosis;Diseases;2024-07-13

4. Evaluating the St. George’s respiratory questionnaire in idiopathic pulmonary fibrosis: a systematic review with meta-analysis of psychometric properties using COSMIN;Discover Social Science and Health;2024-07-02

5. The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial;Respiratory Investigation;2024-07